Cargando…

Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study

IMPORTANCE: The incidence of age-related macular degeneration (AMD) is unknown in Africa. OBJECTIVE: To estimate the 6-year cumulative incidence and progression of AMD in older adults (≥50 years old) in Nakuru, Kenya. DESIGN, SETTING, AND PARTICIPANTS: This study assessed a population-based cohort w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bastawrous, Andrew, Mathenge, Wanjiku, Peto, Tunde, Shah, Nisha, Wing, Kevin, Rono, Hillary, Weiss, Helen A., Macleod, David, Foster, Allen, Burton, Matthew, Kuper, Hannah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710264/
https://www.ncbi.nlm.nih.gov/pubmed/28494075
http://dx.doi.org/10.1001/jamaophthalmol.2017.1109
_version_ 1783282927130378240
author Bastawrous, Andrew
Mathenge, Wanjiku
Peto, Tunde
Shah, Nisha
Wing, Kevin
Rono, Hillary
Weiss, Helen A.
Macleod, David
Foster, Allen
Burton, Matthew
Kuper, Hannah
author_facet Bastawrous, Andrew
Mathenge, Wanjiku
Peto, Tunde
Shah, Nisha
Wing, Kevin
Rono, Hillary
Weiss, Helen A.
Macleod, David
Foster, Allen
Burton, Matthew
Kuper, Hannah
author_sort Bastawrous, Andrew
collection PubMed
description IMPORTANCE: The incidence of age-related macular degeneration (AMD) is unknown in Africa. OBJECTIVE: To estimate the 6-year cumulative incidence and progression of AMD in older adults (≥50 years old) in Nakuru, Kenya. DESIGN, SETTING, AND PARTICIPANTS: This study assessed a population-based cohort with 6-year follow-up of 4414 participants who had a complete assessment. Random cluster sampling with probability proportionate to size procedures was used to select a representative, cross-sectional sample of adults 50 years and older from January 26, 2007, through November 11, 2008. A 6-year follow-up was undertaken from January 7, 2013, through March 12, 2014. On both occasions, a comprehensive ophthalmic examination was performed that included logMAR visual acuity, digital retinal photography, and grading of images at Moorfields Eye Hospital Reading Centre. Data were collected on general health and risk factors. MAIN OUTCOMES AND MEASURES: Incident AMD in participants with no AMD at baseline and progression from early to late AMD. RESULTS: A total of 1453 of the 2900 individuals (50.1%) at risk for AMD were followed up after 6 years (mean [SD] age, 60.7 [8.2] years; 635 female [49.5%]; 799 Kikuyu [62.3%], 324 Kalenjin [25.3%], and 159 other [12.4%]); 1282 had data on AMD status at follow-up. Of these, 202 developed early AMD, and no participants developed late AMD. The 6-year weighted (for loss to follow-up) cumulative incidence of early AMD was 164.2 per 1000 persons (95% CI, 136.7-195.9 per 1000 persons). Two individuals with baseline early AMD from the 142 at risk had developed late AMD at follow-up, with a 6-year cumulative incidence of progression from early to late AMD of 24.5 per 1000 persons (95% CI, 5.0-111.7 per 1000 persons). Cumulative incidence of AMD increased with age (≥80 years old vs 50-59 years old: 1.8; 95% CI, 0.9-3.5) and was higher in women (female vs male: 1.6; 95% CI, 1.2-2.1) and persons with diabetes (diabetes vs no diabetes: 1.7; 95% CI, 1.0-2.8). CONCLUSIONS AND RELEVANCE: In Kenya, more than 100 000 estimated new cases of AMD, mainly early AMD, will develop every year in individuals 50 years or older, although a 50% loss to follow-up and wide CIs for progression to late AMD limit definitive conclusions from these findings.
format Online
Article
Text
id pubmed-5710264
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-57102642017-12-06 Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study Bastawrous, Andrew Mathenge, Wanjiku Peto, Tunde Shah, Nisha Wing, Kevin Rono, Hillary Weiss, Helen A. Macleod, David Foster, Allen Burton, Matthew Kuper, Hannah JAMA Ophthalmol Original Investigation IMPORTANCE: The incidence of age-related macular degeneration (AMD) is unknown in Africa. OBJECTIVE: To estimate the 6-year cumulative incidence and progression of AMD in older adults (≥50 years old) in Nakuru, Kenya. DESIGN, SETTING, AND PARTICIPANTS: This study assessed a population-based cohort with 6-year follow-up of 4414 participants who had a complete assessment. Random cluster sampling with probability proportionate to size procedures was used to select a representative, cross-sectional sample of adults 50 years and older from January 26, 2007, through November 11, 2008. A 6-year follow-up was undertaken from January 7, 2013, through March 12, 2014. On both occasions, a comprehensive ophthalmic examination was performed that included logMAR visual acuity, digital retinal photography, and grading of images at Moorfields Eye Hospital Reading Centre. Data were collected on general health and risk factors. MAIN OUTCOMES AND MEASURES: Incident AMD in participants with no AMD at baseline and progression from early to late AMD. RESULTS: A total of 1453 of the 2900 individuals (50.1%) at risk for AMD were followed up after 6 years (mean [SD] age, 60.7 [8.2] years; 635 female [49.5%]; 799 Kikuyu [62.3%], 324 Kalenjin [25.3%], and 159 other [12.4%]); 1282 had data on AMD status at follow-up. Of these, 202 developed early AMD, and no participants developed late AMD. The 6-year weighted (for loss to follow-up) cumulative incidence of early AMD was 164.2 per 1000 persons (95% CI, 136.7-195.9 per 1000 persons). Two individuals with baseline early AMD from the 142 at risk had developed late AMD at follow-up, with a 6-year cumulative incidence of progression from early to late AMD of 24.5 per 1000 persons (95% CI, 5.0-111.7 per 1000 persons). Cumulative incidence of AMD increased with age (≥80 years old vs 50-59 years old: 1.8; 95% CI, 0.9-3.5) and was higher in women (female vs male: 1.6; 95% CI, 1.2-2.1) and persons with diabetes (diabetes vs no diabetes: 1.7; 95% CI, 1.0-2.8). CONCLUSIONS AND RELEVANCE: In Kenya, more than 100 000 estimated new cases of AMD, mainly early AMD, will develop every year in individuals 50 years or older, although a 50% loss to follow-up and wide CIs for progression to late AMD limit definitive conclusions from these findings. American Medical Association 2017-06-08 2017-06 /pmc/articles/PMC5710264/ /pubmed/28494075 http://dx.doi.org/10.1001/jamaophthalmol.2017.1109 Text en Copyright 2017 Bastawrous A et al. JAMA Ophthalmology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Bastawrous, Andrew
Mathenge, Wanjiku
Peto, Tunde
Shah, Nisha
Wing, Kevin
Rono, Hillary
Weiss, Helen A.
Macleod, David
Foster, Allen
Burton, Matthew
Kuper, Hannah
Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study
title Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study
title_full Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study
title_fullStr Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study
title_full_unstemmed Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study
title_short Six-Year Incidence and Progression of Age-Related Macular Degeneration in Kenya: Nakuru Eye Disease Cohort Study
title_sort six-year incidence and progression of age-related macular degeneration in kenya: nakuru eye disease cohort study
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710264/
https://www.ncbi.nlm.nih.gov/pubmed/28494075
http://dx.doi.org/10.1001/jamaophthalmol.2017.1109
work_keys_str_mv AT bastawrousandrew sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy
AT mathengewanjiku sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy
AT petotunde sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy
AT shahnisha sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy
AT wingkevin sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy
AT ronohillary sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy
AT weisshelena sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy
AT macleoddavid sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy
AT fosterallen sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy
AT burtonmatthew sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy
AT kuperhannah sixyearincidenceandprogressionofagerelatedmaculardegenerationinkenyanakurueyediseasecohortstudy